Atara Biotherapeutics, Inc.
ATRA
$9.81
$1.0311.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.48M | 13.71M | 22.32M | 13.84M | 42.50M |
| Total Receivables | 1.25M | 1.91M | -- | 8.88M | 1.48M |
| Inventory | -- | -- | -- | -- | 10.66M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.48M | 2.81M | 2.45M | 4.47M | 10.26M |
| Total Current Assets | 12.21M | 18.43M | 24.77M | 27.18M | 64.89M |
|
|
|||||
| Total Current Assets | 12.21M | 18.43M | 24.77M | 27.18M | 64.89M |
| Net Property, Plant & Equipment | 7.14M | 10.85M | 11.20M | 32.01M | 41.10M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 886.00K | 881.00K | 927.00K | 2.84M | 3.10M |
| Total Assets | 20.24M | 30.17M | 36.90M | 62.04M | 109.10M |
|
|
|||||
| Total Accounts Payable | 127.00K | 318.00K | 1.76M | 1.38M | 4.37M |
| Total Accrued Expenses | 3.30M | 5.11M | 8.95M | 16.61M | 20.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.03M | 1.95M | 2.24M | 13.92M | 13.92M |
| Total Finance Division Other Current Liabilities | 10.47M | 10.68M | 1.61M | 15.98M | 95.47M |
| Total Other Current Liabilities | 10.47M | 10.68M | 1.61M | 15.98M | 95.47M |
| Total Current Liabilities | 14.92M | 18.06M | 14.56M | 47.89M | 134.57M |
|
|
|||||
| Total Current Liabilities | 14.92M | 18.06M | 14.56M | 47.89M | 134.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.35M | 15.01M | 15.43M | 28.03M | 29.91M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.47M | 33.74M | 41.95M | 41.19M | 41.89M |
| Total Liabilities | 58.74M | 66.80M | 71.94M | 117.11M | 206.38M |
|
|
|||||
| Common Stock & APIC | 1.98B | 1.98B | 1.98B | 1.96B | 1.96B |
| Retained Earnings | -2.02B | -2.02B | -2.01B | -2.02B | -2.05B |
| Treasury Stock & Other | 1.00K | 2.00K | -- | -- | 8.00K |
| Total Common Equity | -38.50M | -36.63M | -35.04M | -55.07M | -97.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.50M | -36.63M | -35.04M | -55.07M | -97.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.50M | -36.63M | -35.04M | -55.07M | -97.28M |
|
|
|||||